comparemela.com

A GLP-1 receptor agonist commonly used to treat type 2 diabetes could help reduce the development of motor skills deterioration in people with early-stage Parkinson’s, a new study indicates.

Related Keywords

France ,United States ,American ,Daniel Truong ,Ozempic Wegovy ,Robert Gabbay ,Peter Dazeley Getty ,American Diabetes Association ,Share On Pinterest Research ,New England Journal ,Medical News Today ,Truong Neuroscience Institute ,Memorialcare Orange Coast Medical Center ,Fountain Valley ,Clinical Parkinsonism ,Related Disorders ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.